Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Frigault

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Blood|February 28, 2019
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cellsPhilipp Karschnia, Justin T Jordan, Deborah A Forst, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Annals of Clinical and Translational Neurology|August 7, 2023
Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEGChristine A Eckhardt, Haoqi Sun, Preeti Malik, et al.
Blood Advances|November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myelomaAndrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Blood|September 12, 2022
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19Peter G Miller, Geoffrey G Fell, Brody H Foy, et al.
Frontiers in Oncology|April 4, 2022
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial TumorsDavid S Hong, Marcus O Butler, Russell K Pachynski, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Blood|February 28, 2019
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cellsPhilipp Karschnia, Justin T Jordan, Deborah A Forst, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Annals of Clinical and Translational Neurology|August 7, 2023
Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEGChristine A Eckhardt, Haoqi Sun, Preeti Malik, et al.
Blood Advances|November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myelomaAndrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Blood|September 12, 2022
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19Peter G Miller, Geoffrey G Fell, Brody H Foy, et al.
Frontiers in Oncology|April 4, 2022
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial TumorsDavid S Hong, Marcus O Butler, Russell K Pachynski, et al.
Pageof 12